EOFlow Officially Launches iOS Version of the EOPatch App ‘Narsha’
EOFlow Announces Record Revenue for First Quarter 2022; Revenue of 949 Million KRW which is 137% of Last Year’s Annual Revenue
EOFlow Has its First Clinical Study on EOPatch Published in Diabetes & Metabolism Journal
EOFlow to Supply KRW48.8bn Worth of EOPatch to Gulf Drug of UAE
EOFLOW and K-Bio Health sign an MOU
EOFLOW's product chosen as a 'Top 100 Science Spinoffs'
EOFLOW mentioned as a major new medical device company in an article
EOFLOW will be at the 2018 EASD, Berlin, Germany (10/2 - 10/4)
EOFLOW presents to President Moon
EOFLOW's JDRF partnership chosen as a top-10 event
EOFLOW will be at the 2018 ADA, Orlando (6/23-25)
EOFLOW covered in a major newspaper article
EOFLOW investment story on TV
EOFLOW closes two back-to-back rounds of funding